Recent Patents on CNS Drug Discovery

ISSN: 1574-8898 - Volume 3, 3 Issues, 2008

Upcoming titles of Recent Patents on CNS Drug Discovery:

Contents


DNA methylome-encoded information in the pathogenesis of autoimmunity diseases
Yong Teng

Recent advancements in anti-migraine drug research: focus on attempts to decrease cortical/neuronal hyperexcitability
Istvan Tarnawa

Stem cells: regenerative medicine in neurodegenerative disorder
Rajnish Chaturvedi

Analgesic peptides
Miguel Castanho

Leviteracetam in epilepsy
AS Girija

The Disease-modifying therapies for the treatment of Alzheimer's disease
Maria Luisa Onor

Off-label uses of gabapentin
Sirous Jafarian

New Frontiers in Alcoholism and Addiction Treatment
Felice Nava

The therapeutic effects of immunomodulation on CNS injuries
Takekazu Kubo

Repetitive vs deep transcranial stimulation in the treatment of mood disorders
Pinhas Dannon

Recent Patents on CNS Drug Discovery: Acute Injury
Robert Vink

Nitric Oxide and Arginine metabolism as new targets in the CNS
Marcella Faria de Almeida Prado

Idiopathic Intracranial Hypertension May Be Due to Reactivation of Latent Cerebral Toxoplasmosis Probably Because of Disturbances in the Host and/or Toxoplasma gondii immune Defense Mechanisms. Effects of Medications and Biologic Substances
Joseph Prandota

Anti-amyloid agents that are in the pipeline and considered as the next generation treatment for Alzheimer’s disease
Kye Kim

Ligands and drugs for monoamine transporters
Magnus W. Walter, Peter T. Gallagher and Michael J. O’Neill

Progress on the development of ligands 7 nicotinic⊕2 and ⊕4⊕that are selective for acetycholine receptors (nAChRs).
Martine Keenan, Colin P. Dell and Michael J. O’Neill

Compounds and uses thereof in modulating amyloid beta
Cheng, Soan; Comer, Daniel, D.; Mao, Long; Balow, Guity, P.; Pleynet, David

Recent Development of Serotonin Transporter Inhibitors for a new Psychotic Drug
Hyun-Joon Ha

G.Protein- coupled receptors (GPCR)
William K.Lim

Current experimental therapy for Alzheimer's disease
Dr.Weidong Le

Cannabinoids as CNS potential drugs
Ahmed Galal

Use of alpha-amylase in human stress research
Anda van STegeren

Contemporary anticholinesterase pharmaceuticals of natural origin for the treatment of Alzheimer's disease
Gürdal Orhan, Ilkay Orhan, Nese Subutay-Öztekin, Fikri Ak, Bilge Sener

The role of melatonin in the immuno-neuro-psychology of mental disorders
Maria D. Maldonado, Maria A. Pérez-San-Gregorio and Russel J. Reiter

Defender against Alzheimer’s disease
Masaaki Matsuoka

Neglected Diseases that Affect the CNS: an Overview
Boechat N. Bastos, M.M., Carvalho, A.S., Domingos, J.L.O. and Mayer, L.M.U